The microbiome in the lower respiratory tract

Area of Science:

• Microbiology
• Pulmonology
• Genomics

Background:

• The lung microbiome's role in respiratory diseases is gaining attention with new sequencing technologies.
• Understanding bacterial flora in the lungs is crucial for deciphering disease pathogenesis and progression.

Purpose of the Study:

• To review the current understanding of the lung microbiome in various pulmonary diseases.
• To explore how new technologies can aid in developing treatment and prevention strategies for lung diseases by targeting the microbiome.

Main Methods:

• Utilizing next-generation sequencing (NGS) to analyze bacterial 16S ribosomal RNA gene sequences for rapid identification of bacterial phyla and genera.
• Employing Sanger sequencing with clone library construction to identify specific pathogenic bacterial species and their abundance in respiratory samples.

Main Results:

• NGS allows for rapid, large-scale estimation of bacterial sequences in respiratory samples.
• Combined techniques reveal novel bacterial insights into infectious lung diseases like pneumonia and lung abscess.
• Semi-quantification of bacterial burden provides new information on specific lung infections.

Conclusions:

• Advances in microbiome analysis technologies are crucial for understanding lung diseases.
• Targeting the lung microbiome presents a promising avenue for novel therapeutic and preventive strategies in pulmonary medicine.